Skip to content

Aurogel

by Aurolab

Ref Nil

Aurogel (Nil) is a Class IIb device made by Aurolab, registered in EUDAMED on 13 Oct 2026 (Basic UDI-DI B-803878AG0001SLGX), active as of 24 Oct 2026.

Active European Union

CE MDD

Valid until

No date given

EUDAMED holds no validity date

FDA recalls

Not applicable

No FDA record for this device

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Source EUDAMED, synced 24 Oct 2026.

Regulatory status

as of registry sync 24 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDD NumberB-803878AG0001SLGX Basic UDI-DI D-803878AG0001SLGXUDI-DIDate13 Oct 2026RegisteredStatusActive

Official records

Coverage

1 jurisdiction

SwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

European Union — CE/MDD Active

Specification

EUDAMED

Device name
Sodium Hyaluronate
Model / reference
Nil
Primary DI / UDI-DI
D-803878AG0001SLGX
Basic UDI-DI
B-803878AG0001SLGX
EMDN code
Q02030399 Ophthalmology, viscoelastic fluids - other
Device class
Class IIb
EU registration type
Legacy device (under a directive)
EU market of registration
Germany

Manufacturer details

EUDAMED SRN
IN-MF-000007255
Authorised representative
mdi Europa GmbH DE-AR-000006218

Similar devices in this category

Other devices filed under OPHTHALMOLOGY, VISCOELASTIC FLUIDS.

Other devices from Aurolab

See all devices from Aurolab →

Properties

  • Supplied sterile
Other properties (11, all answered No)